关注
Sergi Pascual
Sergi Pascual
MD, PhD
没有经过验证的电子邮件地址
标题
引用次数
引用次数
年份
Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings
J Gea, S Pascual, C Casadevall, M Orozco-Levi, E Barreiro
Journal of thoracic disease 7 (10), E418, 2015
2462015
Oxidative stress, redox signaling pathways, and autophagy in cachectic muscles of male patients with advanced COPD and lung cancer
E Puig-Vilanova, DA Rodriguez, J Lloreta, P Ausin, S Pascual-Guardia, ...
Free Radical Biology and Medicine 79, 91-108, 2015
1842015
Redox balance and carbonylated proteins in limb and heart muscles of cachectic rats
J Marin-Corral, CC Fontes, S Pascual-Guardia, F Sanchez, M Olivan, ...
Antioxidants & redox signaling 12 (3), 365-380, 2010
932010
Respiratory diseases and muscle dysfunction
J Gea, C Casadevall, S Pascual, M Orozco-Levi, E Barreiro
Expert review of respiratory medicine 6 (1), 75-90, 2012
912012
Metabolic signatures associated with severity in hospitalized COVID-19 patients
J Marín-Corral, J Rodríguez-Morató, A Gomez-Gomez, S Pascual-Guardia, ...
International journal of molecular sciences 22 (9), 4794, 2021
842021
Oral low-dose theophylline on top of inhaled fluticasone-salmeterol does not reduce exacerbations in patients with severe COPD: a pilot clinical trial
BG Cosío, H Shafiek, A Iglesias, A Yanez, R Córdova, A Palou, ...
Chest 150 (1), 123-130, 2016
652016
Vastus lateralis fiber shift is an independent predictor of mortality in chronic obstructive pulmonary disease
MS Patel, SA Natanek, G Stratakos, S Pascual, J Martínez-Llorens, ...
American journal of respiratory and critical care medicine 190 (3), 350-352, 2014
632014
Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients
L Millares, S Pascual, C Montón, M García-Núñez, C Lalmolda, R Faner, ...
BMC Pulmonary Medicine 19, 1-9, 2019
532019
Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring
M Crespo, A Barrilado-Jackson, E Padilla, J Eguía, D Echeverria-Esnal, ...
American Journal of Transplantation 22 (3), 786-800, 2022
482022
Aspiration risk factors, microbiology, and empiric antibiotics for patients hospitalized with community-acquired pneumonia
J Marin-Corral, S Pascual-Guardia, F Amati, S Aliberti, JR Masclans, ...
Chest 159 (1), 58-72, 2021
452021
Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study
S Pascual, J Feimer, A De Soyza, J Sauleda Roig, J Haughney, ...
NPJ primary care respiratory medicine 25 (1), 1-7, 2015
442015
Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point …
M Carugati, S Aliberti, G Sotgiu, F Blasi, A Gori, R Menendez, M Encheva, ...
European Journal of Clinical Microbiology & Infectious Diseases 39, 1513-1525, 2020
412020
Structural differences in the diaphragm of patients following controlled vs assisted and spontaneous mechanical ventilation
J Marin-Corral, I Dot, M Boguñá, L Cecchini, A Zapatero, MP Gracia, ...
Intensive Care Medicine 45, 488-500, 2019
392019
Immunologic resilience and COVID-19 survival advantage
GC Lee, MI Restrepo, N Harper, MS Manoharan, AM Smith, JA Meunier, ...
Journal of Allergy and Clinical Immunology 148 (5), 1176-1191, 2021
372021
Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised …
S Andreas, M Testa, L Boyer, G Brusselle, W Janssens, E Kerwin, A Papi, ...
The Lancet Respiratory Medicine 10 (5), 435-446, 2022
332022
Clinical management of chronic obstructive pulmonary disease patients with muscle dysfunction
J Gea, C Casadevall, S Pascual, M Orozco-Levi, E Barreiro
Journal of thoracic disease 8 (11), 3379, 2016
322016
Hospital admissions and mortality in patients with COPD exacerbations and vertebral body compression fractures
S Pascual-Guardia, D Badenes-Bonet, C Martin-Ontiyuelo, F Zuccarino, ...
International journal of chronic obstructive pulmonary disease, 1837-1845, 2017
292017
Phenotypic characterisation of early COPD: a prospective case–control study
BG Cosío, S Pascual-Guardia, A Borras-Santos, G Peces-Barba, S Santos, ...
ERJ Open Research 6 (4), 2020
282020
The phosphodiesterase-4 inhibitor roflumilast reverts proteolysis in skeletal muscle cells of patients with COPD cachexia
E Barreiro, E Puig-Vilanova, A Salazar-Degracia, S Pascual-Guardia, ...
Journal of Applied Physiology 125 (2), 287-303, 2018
282018
The BIOMEPOC project: personalized biomarkers and clinical profiles in chronic obstructive pulmonary disease
J Gea, S Pascual, A Castro-Acosta, C Hernández-Carcereny, R Castelo, ...
Archivos de Bronconeumología (English Edition) 55 (2), 93-99, 2019
262019
系统目前无法执行此操作,请稍后再试。
文章 1–20